Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display (Q39022761)

8 September 2017

Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display (English)

1 reference

8 September 2017

0 references

3

George P Smith

0 references

author name string

Benjamin M Larimer

1

1 reference

8 September 2017

William D Thomas

2

1 reference

8 September 2017

George P Smith

3

1 reference

8 September 2017

Susan L Deutscher

4

1 reference

8 September 2017

1 August 2014

1 reference

Molecular Imaging and Biology

8 September 2017

1 reference

8 September 2017

16

1 reference

8 September 2017

4

1 reference

8 September 2017

449-458

1 reference

https://scigraph.springernature.com/pub.10.1007/s11307-014-0724-5

8 September 2017

0 references

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Is phage display technology on target for developing peptide-based cancer drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Combinatorial discovery of tumor targeting peptides using phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Identification of peptide sequences that bind the Thomsen-Friedenreich cancer-associated glycoantigen from bacteriophage peptide display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Targeting tumor vasculature with homing peptides from phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Stepwise intraclonal maturation of antibody affinity through somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Combinatorial evolution of high-affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Basic local alignment search tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

SAROTUP: scanner and reporter of target-unrelated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Antibody pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Phage display in molecular imaging and diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Diversity of phage-displayed libraries of peptides during panning and amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Reducing renal uptake of radiolabeled peptides using albumin fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0724-5

Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells

21 January 2018

1 reference

12 December 2020

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

12 December 2020

Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells

1 reference

12 December 2020

Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

1 reference

12 December 2020

A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

1 reference

12 December 2020

Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues

1 reference

12 December 2020

Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.

1 reference

12 December 2020

In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas

1 reference

12 December 2020

PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.

1 reference

12 December 2020

10.1007/S11307-014-0724-5

Identifiers

DOI

1 reference

8 September 2017

1 reference